88,689 authorized patents, 76 products worth over 10 billion yuan expiring—Interpretation of pharmaceutical patent data for the first half of 2026
Introduction: In 2026, domestic pharmaceutical innovation will enter a critical period of accelerated iteration. Patent examination has become increasingly strict, major drugs are expiring in concentrated
